Answer
Yes, tralokinumab can cause a transient increase in blood eosinophils, with mean counts returning to baseline during continued treatment.
Sources for this answer
- Adtralza 150 mg solution for injection in pre-filled syringeLeo Laboratories Limited · emc · SmPC §4.8 Undesirable effects · Version 9Document updated
Sources checked